The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Caron Jacobson | ASCO 2018 | Overview of CAR-T and other vehicles for immunotherapy

Jun 5, 2018

ASCO Annual Meeting, 1-5 June 2018, Chicago, IL
Caron Jacobson
Dana-Farber Cancer Institute, Boston, US

Interview topic: Gene expression profiling in ABC-type DLBCL patients from the ROBUST phase III trial

Caron Jacobson | ASCO 2018 | Overview of CAR-T and other vehicles for immunotherapy